Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Conclusions and clinical perspectives

Date

10 Oct 2016

Session

Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Presenters

Felix Feng

Authors

F. Feng

Author affiliations

Radiation Oncology, University of Michigan, 48109-5010 - Ann Arbor/US

More

Resources

Reserved to ESMO members

Login Join ESMO

Watch the webcast

Resources from the same session

10 Oct 2016

What is the role of CTCs?

Presenter: Howard Scher

Session: Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Resources:

Presentation

Webcast

10 Oct 2016

Using circulating tumour DNA studies to improve the management of prostate cancer patients

Presenter: Gerhardt Attard

Session: Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Resources:

Presentation

Webcast

10 Oct 2016

Translating the genomics landscape into clinical practice

Presenter: Rob Bristow

Session: Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Resources:

Presentation

Webcast

10 Oct 2016

Introduction

Presenter: David Olmos

Session: Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Resources:

Webcast